Pancreatic adenocarcinoma is among the most fatal of gastrointestinal cancers. Recent in vitro studies showed that tumors are able to develop several escape mechanisms. We hypothesized that regulatory T cells (Treg) may impair anti-tumor immune responses. Therefore, we investigated the role of immune-mediated pathways in invasive pancreatic cancer.
Blood and tumor samples were analyzed in 14 patients undergoing surgery for pancreatic adenocarcinoma (UICC stages II to IV) by ELISA, immunohistology, and real-time RT-PCR techniques. The expression, distribution, and protein products of the following gene classes were analyzed:Treg (CD4, CD25, CD8, IDO, Foxp3), costimulatory molecules (CD28, CTLA-4), transcription factors (GITR, GATA-3), apoptotic markers (Bcl-2, Fas, FasL), cytokines (IFN-γ, IL-6/10), tumor suppressors (p53, APC), and tumor marker (CEA). Invasive pancreatic carcinomas show relatively low levels in expression of genes associated with immune activation and regulation. This might indicate insufficient antitumor immune responses against the tumor. In addition, gene expression profiles differ significantly between samples obtained from the tumor center versus the tumor border line.
